Swapna Joshi, PhD

Dr. Joshi co-leads the Integrative Biostatistics and Bioinformatics Core at the Goodman-Luskin Microbiome Center. Her research focuses on developing epigenetic biomarkers for gastrointestinal diseases, with an emphasis on differential diagnosis of irritable bowel syndrome. Dr. Joshi has published in peer-reviewed journals such as Nature and Gastroenterology and serves as a review editor for several journals as well as a guest editor for Frontiers in Physiology. She has received multiple honors, including Early Career Investigator recognition at Digestive Disease Week in 2018 and 2022, and is a co-inventor on two U.S. patents related to DNA methylation-based biomarkers for gastrointestinal disorders filed in 2019 and 2023.

Dr. Joshi’s research interests include bioinformatic analysis and integration of genomic, epigenetic, and microbial data to identify diagnostic biomarkers and mechanisms of gastrointestinal (GI) diseases, including irritable bowel syndrome (IBS).